KCNV2

Last updated
KCNV2
Identifiers
Aliases KCNV2 , KV11.1, Kv8.2, RCD3B, potassium voltage-gated channel modifier subfamily V member 2
External IDs OMIM: 607604; MGI: 2670981; HomoloGene: 26423; GeneCards: KCNV2; OMA:KCNV2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_133497

NM_183179

RefSeq (protein)

NP_598004

NP_899002

Location (UCSC) Chr 9: 2.72 – 2.73 Mb Chr 19: 27.3 – 27.31 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Potassium voltage-gated channel subfamily V member 2 is a protein that in humans is encoded by the KCNV2 gene. [5] [6] The protein encoded by this gene is a voltage-gated potassium channel subunit. [5] [6]

Contents

KCNV2 retinopathy

KCNV2 retinopathy, historically referred to as cone dystrophy with supernormal rod electroretinogram, is a rare autosomal recessive inherited retinal dystrophy caused by biallelic pathogenic variants in the KCNV2 gene. [7] The condition typically presents in childhood with reduced visual acuity, photophobia, impaired color vision, and progressive central visual loss, while night vision may be relatively preserved in early stages.

A defining feature of the disorder is a characteristic full-field electroretinography profile. Scotopic responses may show disproportionately large b-wave amplitudes at higher stimulus intensities, whereas photopic responses are markedly delayed and reduced. This electrophysiological pattern is considered highly suggestive of KCNV2-associated retinopathy and may be present even when funduscopic or structural retinal changes are minimal. [8]

The KCNV2 gene encodes a modulatory subunit of voltage-gated potassium channels expressed in photoreceptors. Pathogenic variants are thought to disrupt normal photoreceptor signaling, resulting in combined cone dysfunction and abnormal rod responses. Additional descriptive electrophysiological and genetic case documentation has been made available through open research repositories. [9]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000168263 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000047298 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 Ottschytsch N, Raes A, Van Hoorick D, Snyders DJ (Jun 2002). "Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome". Proc Natl Acad Sci U S A. 99 (12): 7986–91. Bibcode:2002PNAS...99.7986O. doi: 10.1073/pnas.122617999 . PMC   123007 . PMID   12060745.
  6. 1 2 Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X (Dec 2005). "International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels". Pharmacol Rev. 57 (4): 473–508. doi:10.1124/pr.57.4.10. PMID   16382104. S2CID   219195192.
  7. Wu H, Cowing JA, Michaelides M, et al. Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause cone dystrophy with supernormal rod electroretinogram in humans. American Journal of Human Genetics. 2006;79(3):574–579. doi:10.1086/507568.
  8. Wissinger B, Dangel S, Jägle H, et al. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Investigative Ophthalmology & Visual Science. 2008;49(2):751–757. doi:10.1167/iovs.07-0471.
  9. Lindamulage, Suneth Dayan. "Speaking Waves, Silent Genes: The Mystery of the Whispering Retina — Unraveling the ERG–WES Paradox in Cone Dystrophy with Supernormal Rod Response (CDSRR) - First clinically and electrophysiologically reported case of KCNV2 Retinopathy from Sri Lanka". Figshare. Retrieved 2026-01-30 via DOI.

Further reading